{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T22:56:20Z","timestamp":1782514580616,"version":"3.54.5"},"reference-count":56,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100010414","name":"Health Research Board","doi-asserted-by":"publisher","award":["203930\/B\/16\/Z"],"award-info":[{"award-number":["203930\/B\/16\/Z"]}],"id":[{"id":"10.13039\/100010414","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018270","name":"Health Service Executive","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018270","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["640580"],"award-info":[{"award-number":["640580"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","strokejournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Stroke and Cerebrovascular Diseases"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.jstrokecerebrovasdis.2019.02.018","type":"journal-article","created":{"date-parts":[[2019,3,14]],"date-time":"2019-03-14T05:17:12Z","timestamp":1552540632000},"page":"1703-1709","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["Lipid Lowering Therapy, Low-Density Lipoprotein Level and Risk of Intracerebral Hemorrhage \u2013 A Meta-Analysis"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9473-2920","authenticated-orcid":false,"given":"Conor","family":"Judge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Ruttledge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Costello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5446-4175","authenticated-orcid":false,"given":"Robert","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine","family":"Loughlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Alvarez-Iglesias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Ferguson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Gorey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aoife","family":"Nolan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Canavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"O'Halloran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin J.","family":"O'Donnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jstrokecerebrovasdis.2019.02.018_bib0001","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S1474-4422(09)70058-4","article-title":"Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention","volume":"8","author":"Amarenco","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2019.02.018_bib0002","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1161\/STROKEAHA.113.000915","article-title":"Statin therapy should be discontinued in patients with intracerebral hemorrhage","volume":"44","author":"Goldstein","year":"2013","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2019.02.018_bib0003","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1161\/STROKEAHA.113.000916","article-title":"Statin therapy should not be discontinued in patients with intracerebral hemorrhage","volume":"44","author":"Bustamante","year":"2013","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2019.02.018_bib0004","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1161\/01.STR.30.12.2535","article-title":"Different risk factors for different stroke subtypes: association of blood pressure, cholesterol, and antioxidants","volume":"30","author":"Leppala","year":"1999","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2019.02.018_bib0005","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1136\/bmj.38855.610324.80","article-title":"Serum cholesterol, hemorrhagic stroke, ischemic stroke, and myocardial infarction: Korean national health system prospective cohort study","volume":"333","author":"Ebrahim","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.jstrokecerebrovasdis.2019.02.018_bib0006","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1056\/NEJM198904063201405","article-title":"Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial","volume":"320","author":"Iso","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2019.02.018_bib0007","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1093\/oxfordjournals.aje.a115542","article-title":"The paradox of high risk of stroke in populations with low risk of coronary heart disease","volume":"131","author":"Reed","year":"1990","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2019.02.018_bib0008","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1161\/01.STR.20.11.1460","article-title":"Serum cholesterol and hemorrhagic stroke in the Honolulu Heart Program","volume":"20","author":"Yano","year":"1989","journal-title":"Stroke"},{"issue":"11","key":"10.1016\/j.jstrokecerebrovasdis.2019.02.018_bib0009","first-page":"1059","article-title":"Use of high-intensity statin in patients with ischemic stroke: observation and opinion of a clinical pharmacist in the inpatient setting","volume":"2","author":"Fitzgerald","year":"2014","journal-title":"Austin J Pharmacol Ther"},{"key":"10.1016\/j.jstrokecerebrovasdis.2019.02.018_bib0010","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1161\/STROKEAHA.112.655894","article-title":"Statin therapy and the risk of intracerebral hemorrhage: a meta-analysis of 31 randomized controlled trials","volume":"43","author":"McKinney","year":"2012","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2019.02.018_bib0011","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1056\/NEJMoa061894","article-title":"High-dose atorvastatin after stroke or transient ischemic attack","volume":"355","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2019.02.018_bib0012","doi-asserted-by":"crossref","first-page":"3808","DOI":"10.2174\/138161210794455120","article-title":"The antiplatelet and antithrombotic actions of statins","volume":"16","author":"Mitsios","year":"2010","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.jstrokecerebrovasdis.2019.02.018_bib0014","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1016\/S0140-6736(10)60656-3","article-title":"Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis","volume":"375","author":"Jun","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jstrokecerebrovasdis.2019.02.018_bib0015","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"151","author":"Moher","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2019.02.018_bib0016","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1136\/bmj.326.7382.219","article-title":"Interaction revisited: the difference between two estimates","volume":"326","author":"Altman","year":"2003","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.jstrokecerebrovasdis.2019.02.018_bib0017","doi-asserted-by":"crossref","DOI":"10.18637\/jss.v036.i03","article-title":"Conducting Meta-Analyses in R with the metafor Package","volume":"36","author":"Viechtbauer","year":"2010","journal-title":"J Stat Softw"},{"key":"10.1016\/j.jstrokecerebrovasdis.2019.02.018_bib0018","doi-asserted-by":"crossref","first-page":"33","DOI":"10.5551\/jat1994.8.33","article-title":"A comparison of low versus standard dose pravastatin therapy for the prevention of cardiovascular events in the elderly: the Pravastatin Anti-atherosclerosis Trial in the Elderly (PATE)","volume":"8","author":"Ito","year":"2001","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.jstrokecerebrovasdis.2019.02.018_bib0019","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJMoa043545","article-title":"Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis","volume":"353","author":"Wanner","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2019.02.018_bib0020","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1056\/NEJMoa1600176","article-title":"Cholesterol lowering in intermediate-risk persons without cardiovascular disease","volume":"374","author":"Yusuf","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2019.02.018_bib0021","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1001\/jama.292.11.1307","article-title":"Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: Phase Z of the A to Z Trial","volume":"292","author":"de Lemos","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.jstrokecerebrovasdis.2019.02.018_bib0022","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1016\/S0140-6736(03)13638-0","article-title":"Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomized, placebo-controlled trial","volume":"361","author":"Holdaas","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jstrokecerebrovasdis.2019.02.018_bib0023","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1161\/01.CIR.90.4.1679","article-title":"Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group","volume":"90","author":"Furberg","year":"1994","journal-title":"Circulation."},{"key":"10.1016\/j.jstrokecerebrovasdis.2019.02.018_bib0024","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0140-6736(08)61240-4","article-title":"Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomized, double-blind, placebo-controlled trial","volume":"372","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jstrokecerebrovasdis.2019.02.018_bib0025","doi-asserted-by":"crossref","first-page":"4671","DOI":"10.1210\/jc.2006-1909","article-title":"Effects of atorvastatin on bone in postmenopausal women with dyslipidemia: a double-blind, placebo-controlled, dose-ranging trial","volume":"92","author":"Bone","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jstrokecerebrovasdis.2019.02.018_bib0026","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1001\/jama.285.13.1711","article-title":"Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial","volume":"285","author":"Schwartz","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jstrokecerebrovasdis.2019.02.018_bib0027","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1053\/euhj.1999.1483","article-title":"Effects of lovastatin on progression of non-dilated and dilated coronary segments and on restenosis in patients after PTCA. The Cholesterol Lowering Atherosclerosis PTCA Trial (CLAPT)","volume":"20","author":"Kleemann","year":"1999","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jstrokecerebrovasdis.2019.02.018_bib0028","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.2337\/dc05-2415","article-title":"Efficacy and safety of atorvastatin in the prevention of cardiovascular end points in subjects with type 2 diabetes: The Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in Non-Insulin-Dependent Diabetes Mellitus (ASPEN)","volume":"29","author":"Knopp","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jstrokecerebrovasdis.2019.02.018_bib0029","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1001\/jama.294.19.2437","article-title":"High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial","volume":"294","author":"Pedersen","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.jstrokecerebrovasdis.2019.02.018_bib0030","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJMoa050461","article-title":"Intensive lipid lowering with atorvastatin in patients with stable coronary disease","volume":"352","author":"LaRosa","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2019.02.018_bib0031","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/S0140-6736(10)60310-8","article-title":"Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12,064 survivors of myocardial infarction: a double-blind randomized trial","volume":"376","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jstrokecerebrovasdis.2019.02.018_bib0032","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1056\/NEJMoa040583","article-title":"Intensive versus moderate lipid lowering with statins after acute coronary syndromes","volume":"350","author":"Cannon","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2019.02.018_bib0033","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1001\/jama.288.23.2998","article-title":"Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT)","volume":"288","year":"2002","journal-title":"JAMA J Am Med Assoc"},{"key":"10.1016\/j.jstrokecerebrovasdis.2019.02.018_bib0034","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(02)09327-3","article-title":"MRC\/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebo-controlled trial","volume":"360","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jstrokecerebrovasdis.2019.02.018_bib0035","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/S0140-6736(02)11600-X","article-title":"Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomized controlled trial","volume":"360","author":"Shepherd","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jstrokecerebrovasdis.2019.02.018_bib0036","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM199811053391902","article-title":"Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels","volume":"339","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2019.02.018_bib0037","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0140-6736(03)12948-0","volume":"361","author":"Sever","year":"2003","journal-title":"The Lancet"},{"key":"10.1016\/j.jstrokecerebrovasdis.2019.02.018_bib0038","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1001\/jama.279.20.1615","article-title":"Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS\/TexCAPS","volume":"279","author":"Downs","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.jstrokecerebrovasdis.2019.02.018_bib0039","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0140-6736(04)16895-5","article-title":"Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomized placebo-controlled trial","volume":"364","author":"Colhoun","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jstrokecerebrovasdis.2019.02.018_bib0040","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0140-6736(06)69472-5","article-title":"Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomized controlled trial","volume":"368","author":"Nakamura","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.jstrokecerebrovasdis.2019.02.018_bib0041","article-title":"Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)","volume":"344","year":"1994","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.jstrokecerebrovasdis.2019.02.018_bib0042","first-page":"810","article-title":"Results of the low-dose (20 mg) pravastatin GISSI Prevenzione trial in 4271 patients with recent myocardial infarction: do stopped trials contribute to overall knowledge","volume":"1","year":"2000","journal-title":"Ital heart J."},{"key":"10.1016\/j.jstrokecerebrovasdis.2019.02.018_bib0043","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa0810177","article-title":"Rosuvastatin and cardiovascular events in patients undergoing hemodialysis","volume":"360","author":"Fellstr\u00f6m","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2019.02.018_bib0044","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1056\/NEJMoa0706201","article-title":"Rosuvastatin in older patients with systolic heart failure","volume":"357","author":"Kjekshus","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2019.02.018_bib0045","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"Ridker","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2019.02.018_bib0046","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJM199610033351401","article-title":"The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels","volume":"335","author":"Sacks","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2019.02.018_bib0047","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.ebiom.2015.08.006","article-title":"The Japan Statin Treatment Against Recurrent Stroke (J-STARS): a multicenter, randomized, open-label, parallel-group study","volume":"2","author":"Hosomi","year":"2015","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jstrokecerebrovasdis.2019.02.018_bib0048","doi-asserted-by":"crossref","unstructured":"Treatment with atorvastatin to the national cholesterol educational program goals versus usual care in secondary coronary heart disease prevention. The greek atorvastatin on coronary-heart-disease evaluation (greace) study. Atheroscler Suppl. 2002;3:70.","DOI":"10.1016\/S1567-5688(02)80026-5"},{"issue":"4","key":"10.1016\/j.jstrokecerebrovasdis.2019.02.018_bib0049","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1185\/030079902125000787","article-title":"Treatment with atorvastatin to the National Cholesterol Educational Program goal versus' usual'care in secondary coronary heart disease prevention","volume":"18","author":"Athyros","year":"2002","journal-title":"Current medical research and opinion"},{"key":"10.1016\/j.jstrokecerebrovasdis.2019.02.018_bib0050","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa1410489","article-title":"Ezetimibe added to statin therapy after acute coronary syndromes","volume":"372","author":"Cannon","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2019.02.018_bib0051","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1056\/NEJM198711123172001","article-title":"Helsinki heart study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia","volume":"317","author":"Frick","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2019.02.018_bib0052","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1161\/01.STR.4.4.684","article-title":"The treatment of cerebrovascular disease with clofibrate: final report of the veterans administration cooperative study of atherosclerosis, neurology section","volume":"4","year":"1973","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2019.02.018_bib0053","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/S0140-6736(11)60739-3","article-title":"The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomized placebo-controlled trial","volume":"377","author":"Baigent","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jstrokecerebrovasdis.2019.02.018_bib0054","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2019.02.018_bib0055","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1056\/NEJMoa1706444","article-title":"Effects of anacetrapib in patients with atherosclerotic vascular disease","volume":"377","author":"Bowman","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2019.02.018_bib0056","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomized trials","volume":"376","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jstrokecerebrovasdis.2019.02.018_bib0057","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1161\/STR.0b013e318284056a","article-title":"Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"44","author":"Jauch","year":"2013","journal-title":"Stroke"}],"container-title":["Journal of Stroke and Cerebrovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105230571930062X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105230571930062X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T08:05:05Z","timestamp":1764230705000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S105230571930062X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":56,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S105230571930062X"],"URL":"https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2019.02.018","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.735361392.793577309","asserted-by":"object"}]},"ISSN":["1052-3057"],"issn-type":[{"value":"1052-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipid Lowering Therapy, Low-Density Lipoprotein Level and Risk of Intracerebral Hemorrhage \u2013 A Meta-Analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Stroke and Cerebrovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2019.02.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}